Home | Life Sciences Intellectual Property Review
Jan 2, 2025 · Key similarities and differences between the patent systems, particularly in biotech, offer lessons and opportunities for rightsholders, say Daniela Fasoli of Simões Propriedade …
Latest News & Features | Life Sciences Intellectual Property Review
Dec 24, 2024 · Dispute stems from Amneal’s efforts to market generic version of Teva’s inhaler for treating asthma | Precedential decision could restrict how brand-name pharmaceutical …
Outlook for 2025: how Trump and the USPTO will affect life …
Jan 2, 2025 · Key developments for the industry this year include a more pro-patent administration and USPTO changes, say Carla Ji-Eun Kim and Deborah Sterling of Sterne …
Labcorp's bid to invalidate Ravgen's DNA testing patent hits …
2 days ago · Biotech walks away with another win as Fed Circ upholds PTAB decision | Labcorp’s attempt to overturn $373m verdict fails | Court finds Ravgen’s method for preserving DNA in …
Biotechnology | Life Sciences Intellectual Property Review
16 December 2024 A Delaware jury unanimously sided with Sanofi-owned biotech Inhibrx, clearing it of trade secrets misappropriation claims. Amy Candido of Wilson Sonsini shares …
Generics | Life Sciences Intellectual Property Review
Generic drug makers are watching two cases that will determine whether pharmaceutical firms can deduct—rather than capitalise—legal fees for defending against patent infringement suits, …
Magazine Archive | Life Sciences Intellectual Property Review
LSIPR Autumn 2021. This issue examines big pharma's five-step plan, its alternative to the controversial IP waiver. Elsewhere, it analyses the impact of China's latest IP laws, the …
EPO’s new examination guidelines: what you need to know
Apr 6, 2021 · A new edition of the European Patent Office (EPO) Guidelines for Examination came into force on March 1, 2021. Relevant to life sciences, this edition includes a new …
Europe | Life Sciences Intellectual Property Review
9 May 2024 10x Genomics injunction showed the need to take the court ‘really seriously’ says US lawyer | With a focus on efficiency and plaintiff-friendly measures, the UPC's impact on patent …
CRISPR | Life Sciences Intellectual Property Review
9 November 2020 The European Patent Office has released the long-awaited reasoning for its decision to uphold the revocation of a Broad Institute CRISPR/Cas9 patent. In January this …